Associated Papers
Suppression of stress granule formation is a vulnerability imposed by mutant p53.
Thoenen E et al.
Nature Communications, 2025
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions.
Cordani M et al.
Biomolecules, 2024
FAM193A is a positive regulator of p53 activity.
Szwarc MM et al.
Cell Reports, 2023
36897777 (PubMed )
Supplement: NIHMS1887291-supplement-Table_S1.xlsx › SuppFile1
p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations.
Sung YN et al.
Diagnostic Pathology, 2022
36471402 (PubMed )
Supplement: 13000_2022_1273_MOESM1_ESM.docx
Deep Molecular and In Silico Protein Analysis of p53 Alteration in Myelodysplastic Neoplasia and Acute Myeloid Leukemia.
Madarász K et al.
Cells, 2022
Identifying the determinants of response to MDM2 inhibition.
Saiki AY et al.
Oncotarget, 2015
25730903 (PubMed )
Supplement: oncotarget-06-7701-s002.xls › Proliferation
Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
Di Como CJ et al.
Oncogene, 1998
Select a paper to view details